KLAC KLA Corporation

FY2025 10-K
Filed: Aug 8, 2025
Health Care
Optical Instruments & LensesSEC EDGAR

KLA Corporation (KLAC) filed its fiscal year 2025 10-K annual report with the SEC on Aug 8, 2025. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • Core business model: Semiconductor process control and yield management solutions provider
  • Patent portfolio expanded to over 8,500 active patents and 3,500 pending applications as of June 30, 2025
+2 more insights

Management Discussion & Analysis

  • Revenue increased in fiscal 2025 driven by growth in services (22% of total revenue) and Taiwan semiconductor demand; revenue from Chinese customers decreased YoY
  • Gross margin and overall financial performance improved in fiscal 2025 compared to fiscal 2024 due to higher volume and cost management (exact % not provided)
+3 more insights

Risk Factors

  • Regulatory risk: Impact of more stringent U.S. export controls reducing revenue share from China, which declined from 43% to 33% of total revenues in fiscal 2025
  • Geopolitical risk: Significant revenue concentration in Asia, especially Taiwan (27% of total revenues in 2025), exposing firm to regional economic and political changes
+3 more insights

Financial Summary
XBRL

Revenue

$12.2B

Net Income

$4.1B

Net Margin

33.4%

ROE

86.6%

Total Assets

$16.1B

EPS (Diluted)

$30.37

Operating Cash Flow

$4.1B

Source: XBRL data from KLA Corporation FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on KLA Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available